Nxera Pharma Co., Ltd.
Biopharma using SBDD tech to develop medicines for neurology and gastroenterology.
4565 | T
Overview
Corporate Details
- ISIN(s):
- JP3431300007
- LEI:
- Country:
- Japan
- Address:
- 港区赤坂９−７−２
- Website:
- https://www.nxera.life/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Nxera Pharma Co., Ltd. (formerly Sosei Group) is a technology-driven biopharmaceutical company focused on the discovery and development of specialty medicines. Its mission is to accelerate the creation of life-changing treatments for patients with unmet medical needs, both in Japan and globally. The company leverages its proprietary structure-based drug design (SBDD) platform and drug development capabilities to advance a diverse pipeline of therapeutic programs. Nxera Pharma actively seeks partnerships to pursue breakthrough discoveries and bring innovative medicines to market, with a focus on areas such as neurology and gastroenterology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-08 09:06 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 41.8 KB | ||
| 2025-08-08 09:05 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 41.8 KB | ||
| 2025-08-08 08:57 |
Report Publication Announcement
確認書
|
Japanese | 8.4 KB | ||
| 2025-08-08 08:55 |
Interim Report
半期報告書－第36期(2025/01/01－2025/12/31)
|
Japanese | 287.5 KB | ||
| 2025-04-16 08:57 |
Registration Form
訂正有価証券届出書（参照方式）
|
Japanese | 41.6 KB | ||
| 2025-04-16 08:55 |
Registration Form
訂正有価証券届出書（参照方式）
|
Japanese | 41.6 KB | ||
| 2025-04-16 08:53 |
Registration Form
訂正有価証券届出書（参照方式）
|
Japanese | 39.8 KB | ||
| 2025-04-16 08:51 |
Remuneration Information
臨時報告書
|
Japanese | 32.4 KB | ||
| 2025-03-26 08:42 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 42.2 KB | ||
| 2025-03-26 08:41 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 42.2 KB | ||
| 2025-03-26 08:40 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 40.4 KB | ||
| 2025-03-26 08:38 |
Regulatory News Service
臨時報告書
|
Japanese | 28.0 KB | ||
| 2025-03-26 08:37 |
Regulatory News Service
内部統制報告書－第35期(2024/01/01－2024/12/31)
|
Japanese | 23.8 KB | ||
| 2025-03-26 08:36 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | ||
| 2025-03-26 08:35 |
Annual Report
有価証券報告書－第35期(2024/01/01－2024/12/31)
|
Japanese | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all Nxera Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nxera Pharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nxera Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
